Burcu Açıkalın Arıkan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Burcu Açıkalın Arıkan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Özge Eren Korkmaz
Department of Epidemiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Türkiye
5 shared publications - Nurbanu Sezak
Infectious Diseases and Clinical Microbiology Department, Faculty of Medicine, Izmir Democracy University, 35140 Izmir, Turkey
3 shared publications - Osman Hasan Tahsin Kılıç
Department of Psychiatry, Faculty of Medicine, İzmir Democracy University, İzmir, Turkey
2 shared publications - Pelin Soydar
Department of Neurology, Ataturk State Hospital, Aydın, Türkiye
2 shared publications Seval Çalışkan Pala
Department of Public Health, Eskişehir Provincial Health Directorate, Eskişehir, Türkiye
2 shared publications- Bahar Ormen
Department of Infectious Diseases, Katip Çelebi University Atatürk Training and Research Hospital, İzmir, Türkiye
1 shared publication
Latest Publications
- Open Access
- 2 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Antimicrobial resistance and associated risk factors in urinary tract infections diagnosed in the emergency department: a retrospective observational study
Urinary tract infections (UTIs) are among the most common causes of emergency department admissions and represent a major source of antimicrobial use worldwide. The aim of this study was to determine antimicrobial resistance patterns and associated risk factors among patients diagnosed with UTIs in the emergency department. This retrospective observational study included 1,042 adult patients diagnosed with UTIs in the ED of a tertiary referral hospital. Demographic characteristics, clinical findings, urine culture results, antimicrobial susceptibility profiles, and resistance-associated risk factors were analyzed. Gram-negative bacteria accounted for 74.6% of isolates, with Escherichia coli (43.1%) and Klebsiella spp. (22.3%) being the predominant pathogens. High resistance rates were observed for ciprofloxacin (47.6%), ceftriaxone (47.0%), and trimethoprim-sulfamethoxazole (41.3%). ESBL production and carbapenem resistance were detected in 16.9% and 17.9% of Gram-negative isolates, respectively. Recent antibiotic use, indwelling urinary catheterization, and malignancy were identified as independent risk factors for ESBL positivity. Male sex, malignancy, and indwelling urinary catheterization were independently associated with carbapenem resistance. Among Enterococcus spp. isolates, vancomycin resistance remained very low (0.9%), whereas ampicillin resistance was detected in 23.7% of isolates. These findings underscore the critical importance of incorporating local resistance surveillance into empirical treatment decisions, adopting individualized therapeutic approaches, and strengthening antimicrobial stewardship programs in emergency departments.
- 2 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessAntimicrobial resistance and associated risk factors in urinary tract infections diagnosed in the emergency department: a retrospective observational study
Urinary tract infections (UTIs) are among the most common causes of emergency department admissions and represent a major source of antimicrobial use worldwide. The aim of this study was to determine antimicrobial resistance patterns and associated risk factors among patients diagnosed with UTIs in the emergency department. This retrospective observational study included 1,042 adult patients diagnosed with UTIs in the ED of a tertiary referral hospital. Demographic characteristics, clinical findings, urine culture results, antimicrobial susceptibility profiles, and resistance-associated risk factors were analyzed. Gram-negative bacteria accounted for 74.6% of isolates, with Escherichia coli (43.1%) and Klebsiella spp. (22.3%) being the predominant pathogens. High resistance rates were observed for ciprofloxacin (47.6%), ceftriaxone (47.0%), and trimethoprim-sulfamethoxazole (41.3%). ESBL production and carbapenem resistance were detected in 16.9% and 17.9% of Gram-negative isolates, respectively. Recent antibiotic use, indwelling urinary catheterization, and malignancy were identified as independent risk factors for ESBL positivity. Male sex, malignancy, and indwelling urinary catheterization were independently associated with carbapenem resistance. Among Enterococcus spp. isolates, vancomycin resistance remained very low (0.9%), whereas ampicillin resistance was detected in 23.7% of isolates. These findings underscore the critical importance of incorporating local resistance surveillance into empirical treatment decisions, adopting individualized therapeutic approaches, and strengthening antimicrobial stewardship programs in emergency departments.
- Open Access
- 14 November 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1587
Psychiatric symptoms and necroinflammatory activity in chronic hepatitis B: a cross-sectional study
Background: Patients with chronic hepatitis B (CHB) are at risk of developing psychiatric symptoms such as depression, anxiety, and fatigue, which may adversely affect quality of life, treatment adherence, and disease outcomes. Emerging evidence suggests that these psychological symptoms are influenced not only by psychosocial stressors but also by biological mechanisms related to hepatic necroinflammation and fibrosis. This study aimed to investigate the relationship between depression, anxiety, fatigue, and non-invasive liver fibrosis scores in patients with CHB. Methods: In this cross-sectional study, 200 adult CHB patients were consecutively recruited from a university-affiliated hospital outpatient clinic between September 2023 and February 2024. Patients with acute HBV, cirrhosis, hepatocellular carcinoma, psychiatric comorbidities, or major systemic illnesses were excluded. Psychiatric symptoms were assessed using the validated versions of the Hospital Anxiety and Depression Scale (HADS) and the Fatigue Severity Scale (FSS). Liver fibrosis and necroinflammatory activity were evaluated using non-invasive markers, including AST/ALT ratio (AAR), APRI, FIB-4, and Age-Platelet Index (API). Multivariable logistic regression was used to identify independent predictors of depression, anxiety, and fatigue. Results: Of the 200 patients, 21.0% had depression, 6.5% had anxiety, and 27.0% reported significant fatigue. APRI values were significantly higher in patients with fatigue ( p = 0.002), and API scores were significantly higher in those with anxiety ( p = 0.035). No significant association was found between non-invasive fibrosis indices and depression, although patients with higher depression scores tended to have elevated AAR values. Anxiety was more frequent among unmarried individuals ( p < 0.001), and fatigue was more common in patients receiving antiviral treatment ( p = 0.027). Conclusions: Psychiatric symptoms are prevalent among CHB patients and show significant associations with both psychosocial and biological disease factors. Fatigue was associated with hepatic injury reflected by APRI, and anxiety with early fibrosis markers such as API. These findings underscore the need to integrate routine psychiatric screening for depression, anxiety, and fatigue into CHB management, and to address these symptoms through comprehensive, multidisciplinary care approaches to improve patient well-being and treatment adherence. Trial registration: Not applicable. This study is a cross-sectional observational design and did not require prospective registration.
- 14 November 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1587
Open AccessPsychiatric symptoms and necroinflammatory activity in chronic hepatitis B: a cross-sectional study
Background: Patients with chronic hepatitis B (CHB) are at risk of developing psychiatric symptoms such as depression, anxiety, and fatigue, which may adversely affect quality of life, treatment adherence, and disease outcomes. Emerging evidence suggests that these psychological symptoms are influenced not only by psychosocial stressors but also by biological mechanisms related to hepatic necroinflammation and fibrosis. This study aimed to investigate the relationship between depression, anxiety, fatigue, and non-invasive liver fibrosis scores in patients with CHB. Methods: In this cross-sectional study, 200 adult CHB patients were consecutively recruited from a university-affiliated hospital outpatient clinic between September 2023 and February 2024. Patients with acute HBV, cirrhosis, hepatocellular carcinoma, psychiatric comorbidities, or major systemic illnesses were excluded. Psychiatric symptoms were assessed using the validated versions of the Hospital Anxiety and Depression Scale (HADS) and the Fatigue Severity Scale (FSS). Liver fibrosis and necroinflammatory activity were evaluated using non-invasive markers, including AST/ALT ratio (AAR), APRI, FIB-4, and Age-Platelet Index (API). Multivariable logistic regression was used to identify independent predictors of depression, anxiety, and fatigue. Results: Of the 200 patients, 21.0% had depression, 6.5% had anxiety, and 27.0% reported significant fatigue. APRI values were significantly higher in patients with fatigue ( p = 0.002), and API scores were significantly higher in those with anxiety ( p = 0.035). No significant association was found between non-invasive fibrosis indices and depression, although patients with higher depression scores tended to have elevated AAR values. Anxiety was more frequent among unmarried individuals ( p < 0.001), and fatigue was more common in patients receiving antiviral treatment ( p = 0.027). Conclusions: Psychiatric symptoms are prevalent among CHB patients and show significant associations with both psychosocial and biological disease factors. Fatigue was associated with hepatic injury reflected by APRI, and anxiety with early fibrosis markers such as API. These findings underscore the need to integrate routine psychiatric screening for depression, anxiety, and fatigue into CHB management, and to address these symptoms through comprehensive, multidisciplinary care approaches to improve patient well-being and treatment adherence. Trial registration: Not applicable. This study is a cross-sectional observational design and did not require prospective registration.
- 4 September 2025
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 37 (2) , 112-120
Artificial intelligence meets HIV education: Comparing three large language models on accuracy, readability, and reliability
Background: This study compares three large language models (LLMs) in answering common HIV questions, given ongoing concerns about their accuracy and reliability in patient education. Methods: Models answered 63 HIV questions. Accuracy (5-point Likert), readability (Flesch-Kincaid, Gunning Fog, Coleman-Liau), and reliability (DISCERN, EQIP) were assessed. Results: Claude 3.7 Sonnet showed significantly higher accuracy (4.54 ± 0.44) compared to ChatGPT-4o (4.29 ± 0.49) and Gemini Advanced 2.0 Flash (4.31 ± 0.50) ( p < .001). ChatGPT-4o had lower accuracy in disease definition, follow-up, and transmission routes, while Gemini Advanced 2.0 Flash performed poorly in daily life and treatment-related questions. Readability analyses indicated ChatGPT-4o produced the most accessible content according to Flesch-Kincaid and Coleman-Liau indices, whereas Claude 3.7 Sonnet was most comprehensible by Gunning Fog standards. Gemini Advanced 2.0 Flash consistently generated more complex texts across all readability measures ( p < .001). Regarding reliability, Claude 3.7 Sonnet achieved “good” quality on DISCERN, while others were rated “moderate” ( p = .059). On EQIP, Claude 3.7 Sonnet (median 61.8) and ChatGPT-4o (55.3) were classified as “good quality with minor limitations,” whereas Gemini Advanced 2.0 Flash (41.2) was rated “low quality” ( p = .049). Conclusions: Claude 3.7 Sonnet is preferable for accuracy and reliability, while ChatGPT-4o offers superior readability. Selecting LLMs for HIV education should consider accuracy, readability, and reliability, emphasizing regular assessment of content quality and cultural sensitivity.
- 4 September 2025
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 37 (2) , 112-120
Artificial intelligence meets HIV education: Comparing three large language models on accuracy, readability, and reliability
Background: This study compares three large language models (LLMs) in answering common HIV questions, given ongoing concerns about their accuracy and reliability in patient education. Methods: Models answered 63 HIV questions. Accuracy (5-point Likert), readability (Flesch-Kincaid, Gunning Fog, Coleman-Liau), and reliability (DISCERN, EQIP) were assessed. Results: Claude 3.7 Sonnet showed significantly higher accuracy (4.54 ± 0.44) compared to ChatGPT-4o (4.29 ± 0.49) and Gemini Advanced 2.0 Flash (4.31 ± 0.50) ( p < .001). ChatGPT-4o had lower accuracy in disease definition, follow-up, and transmission routes, while Gemini Advanced 2.0 Flash performed poorly in daily life and treatment-related questions. Readability analyses indicated ChatGPT-4o produced the most accessible content according to Flesch-Kincaid and Coleman-Liau indices, whereas Claude 3.7 Sonnet was most comprehensible by Gunning Fog standards. Gemini Advanced 2.0 Flash consistently generated more complex texts across all readability measures ( p < .001). Regarding reliability, Claude 3.7 Sonnet achieved “good” quality on DISCERN, while others were rated “moderate” ( p = .059). On EQIP, Claude 3.7 Sonnet (median 61.8) and ChatGPT-4o (55.3) were classified as “good quality with minor limitations,” whereas Gemini Advanced 2.0 Flash (41.2) was rated “low quality” ( p = .049). Conclusions: Claude 3.7 Sonnet is preferable for accuracy and reliability, while ChatGPT-4o offers superior readability. Selecting LLMs for HIV education should consider accuracy, readability, and reliability, emphasizing regular assessment of content quality and cultural sensitivity.
- 1 May 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (5) , 355-359
Evaluation of patients with vertebral osteomyelitis diagnosis: ten years of experience
Aim An infection of the vertebrae and intervertebral disc is known as vertebral osteomyelitis (VO). Examining the demographics, comorbidity variables, etiologies, significant laboratory results, and diagnostic and therapeutic techniques of VO cases that were monitored and treated over a ten-year period was the goal of this study. Methods Demographic information, clinical symptoms, chronic illnesses, history of vertebral operations, involved vertebral levels, diagnostic methods, leukocyte count (WBC), erythrocyte sedimentation rate (ESR), serum C-reactive protein level (CRP), amount of hematocrit (HTC), results of microbiological cultures, and agent-specific serology results of the cases followed up with VO diagnosis between January 1, 2014 and January 1, 2024 were collected and analyzed from patient files. Results The mean age of the 125 cases included in the study was 57.5±13.8 years, and the M/F ratio was 1/1.7. The presenting complaints were pain (100%), neurological symptoms (60%), fever (15.2%), fatigue (12%), night sweats (4.8%), and weight loss (0.8%). The cases were diagnosed by imaging methods (92%) or microbiological methods (8%). Comorbidities observed included diabetes (20.8%), renal disease (10.4%), rheumatological disease (3.2%), malignancy (1.6%), history of spinal surgery (31.2%), trauma (13.6%), urinary tract infection (7.2%), nonspecific infection (6.4%), and a history of cerebrovascular events (0.8%). The average response time for ESR and CRP related to pain was found to be around the third week. Conclusion Evaluating pain symptoms, planning imaging methods, confirming diagnosis through biopsy, and initiating pathogen-targeted treatment will be significant steps in enhancing the success of VO treatment. ESR and CRP serve as early indicators for follow-up.
- 1 May 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (5) , 355-359
Evaluation of patients with vertebral osteomyelitis diagnosis: ten years of experience
Aim An infection of the vertebrae and intervertebral disc is known as vertebral osteomyelitis (VO). Examining the demographics, comorbidity variables, etiologies, significant laboratory results, and diagnostic and therapeutic techniques of VO cases that were monitored and treated over a ten-year period was the goal of this study. Methods Demographic information, clinical symptoms, chronic illnesses, history of vertebral operations, involved vertebral levels, diagnostic methods, leukocyte count (WBC), erythrocyte sedimentation rate (ESR), serum C-reactive protein level (CRP), amount of hematocrit (HTC), results of microbiological cultures, and agent-specific serology results of the cases followed up with VO diagnosis between January 1, 2014 and January 1, 2024 were collected and analyzed from patient files. Results The mean age of the 125 cases included in the study was 57.5±13.8 years, and the M/F ratio was 1/1.7. The presenting complaints were pain (100%), neurological symptoms (60%), fever (15.2%), fatigue (12%), night sweats (4.8%), and weight loss (0.8%). The cases were diagnosed by imaging methods (92%) or microbiological methods (8%). Comorbidities observed included diabetes (20.8%), renal disease (10.4%), rheumatological disease (3.2%), malignancy (1.6%), history of spinal surgery (31.2%), trauma (13.6%), urinary tract infection (7.2%), nonspecific infection (6.4%), and a history of cerebrovascular events (0.8%). The average response time for ESR and CRP related to pain was found to be around the third week. Conclusion Evaluating pain symptoms, planning imaging methods, confirming diagnosis through biopsy, and initiating pathogen-targeted treatment will be significant steps in enhancing the success of VO treatment. ESR and CRP serve as early indicators for follow-up.
- Open Access
- 23 January 2025
- Published by Springer Nature in Research Square
Anxiety, Depression, Fatique and Necroinflammatory Activity in Chronic Hepatitis B Patients: A Cross-sectional Study
Background Patients with chronic Hepatitis B (CHB) are more likely to experience mental health issues, which can become worse by liver fibrosis and inflammation. This study aimed to investigate the association of CHB-related necroinflammation and fibrosis on these psychiatric symptoms. Methods A cross-sectional analysis was conducted on 200 CHB patients. The degree of liver inflammation and fibrosis was evaluated using non-invasive (AAR, APRI, FIB-4, API) scores. Patients were asked to complete the HADS and FSS measures in order to gauge their psychological condition. Results In this study, 200 patients were examined. Anxiety was present in 6.5%, depression in 21%, and increased fatigue severity in 27%. AAR was significantly higher in patients with depression (p=0.008). FIB-4 score was significantly higher in those with anxiety (p=0.037) and showed a limited significant difference in fatigue (p=0.052). APRI values were significantly higher in the increased fatigue severity group (p=0.004). Multivariate analyses showed that liver fibrosis significantly increased the risk of depression (OR=2.35, p=0.036), and increasing age decreased the risk of depression (p=0.025). Significantly lower anxiety risk was associated with marriege (OR=0.06, p=<0.001). Patients on antiviral therapy had a 2-fold increase in fatigue severity (OR=2.07, p=0.027). Conclusions This study highlights the link between psychiatric symptoms and liver disease progression in CHB patients. The observed associations between liver fibrosis, depression, and fatigue underscore the importance of a holistic approach to CHB management that integrates mental health support. Such an approach may improve patient outcomes and overall quality of life.
- 23 January 2025
- Published by Springer Nature in Research Square
Open AccessAnxiety, Depression, Fatique and Necroinflammatory Activity in Chronic Hepatitis B Patients: A Cross-sectional Study
Background Patients with chronic Hepatitis B (CHB) are more likely to experience mental health issues, which can become worse by liver fibrosis and inflammation. This study aimed to investigate the association of CHB-related necroinflammation and fibrosis on these psychiatric symptoms. Methods A cross-sectional analysis was conducted on 200 CHB patients. The degree of liver inflammation and fibrosis was evaluated using non-invasive (AAR, APRI, FIB-4, API) scores. Patients were asked to complete the HADS and FSS measures in order to gauge their psychological condition. Results In this study, 200 patients were examined. Anxiety was present in 6.5%, depression in 21%, and increased fatigue severity in 27%. AAR was significantly higher in patients with depression (p=0.008). FIB-4 score was significantly higher in those with anxiety (p=0.037) and showed a limited significant difference in fatigue (p=0.052). APRI values were significantly higher in the increased fatigue severity group (p=0.004). Multivariate analyses showed that liver fibrosis significantly increased the risk of depression (OR=2.35, p=0.036), and increasing age decreased the risk of depression (p=0.025). Significantly lower anxiety risk was associated with marriege (OR=0.06, p=<0.001). Patients on antiviral therapy had a 2-fold increase in fatigue severity (OR=2.07, p=0.027). Conclusions This study highlights the link between psychiatric symptoms and liver disease progression in CHB patients. The observed associations between liver fibrosis, depression, and fatigue underscore the importance of a holistic approach to CHB management that integrates mental health support. Such an approach may improve patient outcomes and overall quality of life.
- 1 September 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (9) , 635-639
Risk factors for mortality in healthcare-associated infections caused by klebsiella pneumoniae
Aim Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality in hospitals. This study aimed to evaluate the antibiotic resistance profiles and mortality risk factors associated with Klebsiella pneumoniae in healthcare-associated infections. Methods This cross-sectional, retrospective study was conducted between January 1, 2018, and January 1, 2024. Adult individuals who had K. pneumoniae isolated from clinical samples taken 48 hours after hospitalization and who met healthcare-associated infection criteria were included in the study. The risk factors associated with mortality were evaluated. Results A total of 84 cases of HAIs caused by K. pneumoniae were included in the study, 47 (56%) of whom were male. Among these, 73.8% exhibited carbapenem-resistant Klebsiella pneumoniae (CRC-Kp). Univariate logistic regression identified chronic obstructive pulmonary disease (COPD), absence of fever response on the fifth day, and CRC-Kp growth as significant mortality predictors. Multivariate analysis revealed patients not on hemodialysis (HD) and absence of fever response on the fifth day as significantly associated with mortality, with 23.774 and 121.620 times higher risk, respectively. Conclusion These findings underscore the threat posed by K. pneumoniae infections due to antibiotic resistance and mortality, highlighting the urgent need for effective infection control measures and targeted treatment strategies.
- 1 September 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (9) , 635-639
Risk factors for mortality in healthcare-associated infections caused by klebsiella pneumoniae
Aim Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality in hospitals. This study aimed to evaluate the antibiotic resistance profiles and mortality risk factors associated with Klebsiella pneumoniae in healthcare-associated infections. Methods This cross-sectional, retrospective study was conducted between January 1, 2018, and January 1, 2024. Adult individuals who had K. pneumoniae isolated from clinical samples taken 48 hours after hospitalization and who met healthcare-associated infection criteria were included in the study. The risk factors associated with mortality were evaluated. Results A total of 84 cases of HAIs caused by K. pneumoniae were included in the study, 47 (56%) of whom were male. Among these, 73.8% exhibited carbapenem-resistant Klebsiella pneumoniae (CRC-Kp). Univariate logistic regression identified chronic obstructive pulmonary disease (COPD), absence of fever response on the fifth day, and CRC-Kp growth as significant mortality predictors. Multivariate analysis revealed patients not on hemodialysis (HD) and absence of fever response on the fifth day as significantly associated with mortality, with 23.774 and 121.620 times higher risk, respectively. Conclusion These findings underscore the threat posed by K. pneumoniae infections due to antibiotic resistance and mortality, highlighting the urgent need for effective infection control measures and targeted treatment strategies.
- Open Access
- 29 July 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (07) , 1082-1089
Seroprevalence and Risk Factors for Hepatitis B, Hepatitis C, and HIV in a Substance Abuse Treatment Center
Introduction: Alcohol and substance use disorders are important public health problems with an increased risk for bloodborne and sexually transmitted infections. Objectives: To determine the frequency and risk factors of hepatitis B, hepatitis C and HIV in individuals with drug and alcohol addiction. Methodology: This prospective study was conducted in the outpatient clinic of Alcohol and Substance Abuse Treatment and Education Center (ASATEC), Izmir, Turkey. Detailed anamneses were taken from alcohol and/or drug addicts who applied to the outpatient clinic; HBV, HCV, HIV serology results in the last 6 months were examined. Results: The study group consisted of 478 persons, including 112 (23.4%) alcohol addicts, 322 (67.4%) substance addicts, and 44 (9.2%) combined alcohol and substance addicts. The mean age of the cases was 32 ± 11 years and 432 (90.4%) were male. Drug injection and needle sharing was recorded in 16.5% and 9.8% of participants, respectively. Hepatitis B surface antigen (HBsAg) positivity was found in 2.7%, anti-HCV positivity in 9.6% and HIV Ag/Ab positivity in 1.9% of the cases. Among patients using intravenous drugs, HBsAg positivity was found in 2%, anti-HCV positivity in 55%, while HIV Ag/Ab positivity was not detected. A history of sexually transmitted disease was a risk factor for HBsAg, HIV Ag/Ab positivity. Intravenous drug use, needle sharing and ecstasy use were determined as risk factors for anti-HCV positivity. Conclusions: Risky behaviors for HBV, HCV and HIV transmission are high in alcohol and substance addicts. The use of ecstasy is a novel risk factor for HCV transmission.
- 29 July 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (07) , 1082-1089
Open AccessSeroprevalence and Risk Factors for Hepatitis B, Hepatitis C, and HIV in a Substance Abuse Treatment Center
Introduction: Alcohol and substance use disorders are important public health problems with an increased risk for bloodborne and sexually transmitted infections. Objectives: To determine the frequency and risk factors of hepatitis B, hepatitis C and HIV in individuals with drug and alcohol addiction. Methodology: This prospective study was conducted in the outpatient clinic of Alcohol and Substance Abuse Treatment and Education Center (ASATEC), Izmir, Turkey. Detailed anamneses were taken from alcohol and/or drug addicts who applied to the outpatient clinic; HBV, HCV, HIV serology results in the last 6 months were examined. Results: The study group consisted of 478 persons, including 112 (23.4%) alcohol addicts, 322 (67.4%) substance addicts, and 44 (9.2%) combined alcohol and substance addicts. The mean age of the cases was 32 ± 11 years and 432 (90.4%) were male. Drug injection and needle sharing was recorded in 16.5% and 9.8% of participants, respectively. Hepatitis B surface antigen (HBsAg) positivity was found in 2.7%, anti-HCV positivity in 9.6% and HIV Ag/Ab positivity in 1.9% of the cases. Among patients using intravenous drugs, HBsAg positivity was found in 2%, anti-HCV positivity in 55%, while HIV Ag/Ab positivity was not detected. A history of sexually transmitted disease was a risk factor for HBsAg, HIV Ag/Ab positivity. Intravenous drug use, needle sharing and ecstasy use were determined as risk factors for anti-HCV positivity. Conclusions: Risky behaviors for HBV, HCV and HIV transmission are high in alcohol and substance addicts. The use of ecstasy is a novel risk factor for HCV transmission.
- Open Access
- 2 July 2023
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 48 (2) , 663-668
The value of APRI and FIB-4 scores in detection of liver fibrosis of patients with chronic hepatitis C
Purpose: Infection with hepatitis C virus causes chronic liver damage, fibrosis and in later processes, cirrhosis and liver cancer. Currently, the use of biomarkers, instead of invasive procedures, is recommended to identify liver fibrosis. In this study, we aimed to evaluate the sensitivity and specificity of aspartate aminotransferase (AST) to Platelet Ratio Index (APRI) and Fibrosis-4 Index (FIB-4) scoring for detection of "significant fibrosis" in chronic hepatitis C patients. Materials and Methods: Liver biopsy results and blood test results of 50 patients, infected with chronic hepatitis C, were analyzed. APRI and FIB-4 scores were calculated. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and consistency for APRI and FIB-4 scorings were calculated using a fourfold table. The values of APRI and FIB-4, providing the best specificity and sensitivity in the diagnosis of significant fibrosis, was determined by ROC (receiver operator characteristics curve) analysis. Results: The mean fibrosis stage of 30 patients with significant fibrosis was 2.83±0.74 and the mean patient age was 56.8±13. The sensitivity of APRI ≥ 1.5 to detect significant fibrosis was 16%, the specificity was 90%, PPV was 71% and NPV was 41%. A FIB-4 score of ≥3.25 had a sensitivity of 20%, a specificity of 95%, a PPV of 85% and a NPV of 44%. Conclusion: APRI and FIB-4 have high specificity and PPV in demonstrating significant fibrosis, but have low sensitivity and NPV. The sensitivity of FIB-4 was higher compared to the APRI scoring. More research on this subject is needed, as well as revision of fibrosis scores and development of new fibrosis scores.
- 2 July 2023
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 48 (2) , 663-668
Open AccessThe value of APRI and FIB-4 scores in detection of liver fibrosis of patients with chronic hepatitis C
Purpose: Infection with hepatitis C virus causes chronic liver damage, fibrosis and in later processes, cirrhosis and liver cancer. Currently, the use of biomarkers, instead of invasive procedures, is recommended to identify liver fibrosis. In this study, we aimed to evaluate the sensitivity and specificity of aspartate aminotransferase (AST) to Platelet Ratio Index (APRI) and Fibrosis-4 Index (FIB-4) scoring for detection of "significant fibrosis" in chronic hepatitis C patients. Materials and Methods: Liver biopsy results and blood test results of 50 patients, infected with chronic hepatitis C, were analyzed. APRI and FIB-4 scores were calculated. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and consistency for APRI and FIB-4 scorings were calculated using a fourfold table. The values of APRI and FIB-4, providing the best specificity and sensitivity in the diagnosis of significant fibrosis, was determined by ROC (receiver operator characteristics curve) analysis. Results: The mean fibrosis stage of 30 patients with significant fibrosis was 2.83±0.74 and the mean patient age was 56.8±13. The sensitivity of APRI ≥ 1.5 to detect significant fibrosis was 16%, the specificity was 90%, PPV was 71% and NPV was 41%. A FIB-4 score of ≥3.25 had a sensitivity of 20%, a specificity of 95%, a PPV of 85% and a NPV of 44%. Conclusion: APRI and FIB-4 have high specificity and PPV in demonstrating significant fibrosis, but have low sensitivity and NPV. The sensitivity of FIB-4 was higher compared to the APRI scoring. More research on this subject is needed, as well as revision of fibrosis scores and development of new fibrosis scores.